Index by author
October 01, 2011; Volume 339,Issue 1
Pan, Xueyang
- You have accessRole of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, EndotheliumYan Pan, Tianluo Lei, Bao Teng, Jihong Liu, Jianzhao Zhang, Yu An, Yuan Xiao, Jing Han, Xueyang Pan, Junhua Wang, Heming Yu, Hong Ren and Xuejun LiJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 82-92; DOI: https://doi.org/10.1124/jpet.111.182055
Pan, Yan
- You have accessRole of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion to, and Migration through, EndotheliumYan Pan, Tianluo Lei, Bao Teng, Jihong Liu, Jianzhao Zhang, Yu An, Yuan Xiao, Jing Han, Xueyang Pan, Junhua Wang, Heming Yu, Hong Ren and Xuejun LiJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 82-92; DOI: https://doi.org/10.1124/jpet.111.182055
Pannirselvam, Malar
- You have accessInhibition of Smooth Muscle Myosin as a Novel Therapeutic Target for HypertensionXin Zhao, David Ho, Patricio Abarzúa, Sunil K. Dhar, Xi Wang, Zhiheng Jia, Malar Pannirselvam, David J. Morgans, Fady I. Malik and Stephen F. VatnerJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 307-312; DOI: https://doi.org/10.1124/jpet.111.182402
Patel, Sanjay R.
- You have accessDrug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical MotifsLindsey A. Needham, Alan H. Davidson, Lindsay J. Bawden, Andrew Belfield, Elisabeth A. Bone, Deborah H. Brotherton, Sam Bryant, Michael H. Charlton, Vanessa L. Clark, Stephen J. Davies, Alastair Donald, Francesca A. Day, David Krige, Valérie Legris, Joanne McDermott, Yvonne McGovern, Jo Owen, Sanjay R. Patel, Stéphane Pintat, Richard J. Testar, Graham M. A. Wells, David Moffat and Alan H. DrummondJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 132-142; DOI: https://doi.org/10.1124/jpet.111.183640
Phillips, David R.
- You have accessA Clopidogrel-Insensitive Inducible Pool of P2Y12 Receptors Contributes to Thrombus Formation: Inhibition by Elinogrel, a Direct-Acting, Reversible P2Y12 AntagonistHelena Haberstock-Debic, Patrick Andre, Scott Mills, David R. Phillips and Pamela B. ConleyJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 54-61; DOI: https://doi.org/10.1124/jpet.111.184143
Pintat, Stéphane
- You have accessDrug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical MotifsLindsey A. Needham, Alan H. Davidson, Lindsay J. Bawden, Andrew Belfield, Elisabeth A. Bone, Deborah H. Brotherton, Sam Bryant, Michael H. Charlton, Vanessa L. Clark, Stephen J. Davies, Alastair Donald, Francesca A. Day, David Krige, Valérie Legris, Joanne McDermott, Yvonne McGovern, Jo Owen, Sanjay R. Patel, Stéphane Pintat, Richard J. Testar, Graham M. A. Wells, David Moffat and Alan H. DrummondJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 132-142; DOI: https://doi.org/10.1124/jpet.111.183640
Plunkett, William
- You have accessGenetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid LeukemiaAmit K. Mitra, Kristine R. Crews, Stanley Pounds, Xueyuan Cao, Tanya Feldberg, Yogita Ghodke, Varsha Gandhi, William Plunkett, M. Eileen Dolan, Christine Hartford, Susana Raimondi, Dario Campana, James Downing, Jeffrey E. Rubnitz, Raul C. Ribeiro and Jatinder K. LambaJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 9-23; DOI: https://doi.org/10.1124/jpet.111.182873
Pounds, Stanley
- You have accessGenetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid LeukemiaAmit K. Mitra, Kristine R. Crews, Stanley Pounds, Xueyuan Cao, Tanya Feldberg, Yogita Ghodke, Varsha Gandhi, William Plunkett, M. Eileen Dolan, Christine Hartford, Susana Raimondi, Dario Campana, James Downing, Jeffrey E. Rubnitz, Raul C. Ribeiro and Jatinder K. LambaJournal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 9-23; DOI: https://doi.org/10.1124/jpet.111.182873
In this issue
Advertisement